SCHEMBL5502741

SCHEMBL5502741

COc1cc(C(N)=O)c(N)cc1OCCn1ccnc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 6/20 0.64
TUBB1 Q9H4B7 1/20 0.51
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
POLB P06746 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
EHMT2 Q96KQ7 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5493922 0.84 TBXAS1 (0.55) TBXAS1TUBB1KDM4EPKMLMNA
SCHEMBL5502664 0.76 KDM4E (0.44) KDM4EPKMLMNAKMT2ASMN1; SMN2
SCHEMBL873953 0.76 KDM4E (0.53) KDM4ELMNAKMT2AHTTSMN1; SMN2
SCHEMBL27905206 0.75 KDM4E (0.51) TUBB1KDM4ELMNAKMT2AHTT
SCHEMBL17922746 0.75 KDM4E (0.51) KDM4ELMNAKMT2ASMN1; SMN2CYP1A2
SCHEMBL19405222 0.75 KDM4E (0.51) KDM4ELMNAKMT2ASMN1; SMN2CYP1A2
SCHEMBL15595723 0.74 TBXAS1 (0.64) TBXAS1TUBB1KDM4EPKMLMNA
SCHEMBL348568 0.74 KDM4E (0.69) KDM4ELMNAKMT2AHTTPOLB
Hydrochloric Acid SCHEMBL30949462 0.74 TBXAS1 (0.65) TBXAS1TUBB1KDM4EPKMLMNA
SCHEMBL15595727 0.74 TBXAS1 (0.55) TBXAS1TUBB1KDM4EPKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed